MedTrace Logo

Efficacy of 2 Diet Plans Designed for People With Type II Diabetes on Weight and Health Measures

NCT00198757 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2005-09-20

No results posted yet for this study

Summary

The objective of this study is to evaluate the efficacy of Medifast Plus for Diabetics compared to a standard weight loss treatment program, in terms of changes in weight loss in overweight men and women over an 86 week active weight loss and weight maintenance program. There will be up to 34 weeks active weight loss and 52 weeks weight maintenance. The planned sample size is 80 overweight (BMI 25-40) males and females aged 18-65 with type 2 diabetes. It is anticipated that pre-packaged meal replacements will provide an advantage to those desiring weight loss.

Conditions

Interventions

BEHAVIORAL

Medifast Plus for Diabetics Meal Replacement Supplements

BEHAVIORAL

Standard ADA recommended diet for type 2 diabetics

Sponsors & Collaborators

  • Medifast, Inc.

    collaborator INDUSTRY

  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Lawrence J Cheskin, MD · Johns Hopkins Bloomberg School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-07-31
Completion
2005-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00198757 on ClinicalTrials.gov